NASDAQ
CERo Therapeutics Holdings, Inc. (CERO) has a free cash flow growth of 27.46% as of Friday, May 29, 2026. This represents a 155.11% increase compared to its 12-month average of -49.83%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.